GlassScriptPhysician profile
Crystal Ahn Sol
NPI 1770219818
$5,315.83
in general payments reported to CMS, 2019-2025
17 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $562 · 2023: $1,434 · 2024: $1,957 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,532 · Entertainment: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,531.58 |
| Entertainment | $222.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,323.43 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Sun Pharmaceutical Industries INC. | $964.86 | 2022-2025 | Cequa |
| Oyster Point Pharma, INC. | $421.60 | 2023-2025 | Tyrvaya |
| Glaukos Corporation | $336.55 | 2023-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa, Idose |
| Dompe US, INC. | $335.60 | 2022-2025 | Oxervate |
| Harrow Eye, LLC | $303.25 | 2024-2025 | Vevye |
| Coopervision INC. | $300.18 | 2023-2024 | Misight Contact Lens |
| Abbvie INC. | $277.13 | 2023-2025 | Durysta |
| Optos, INC. | $222.25 | 2024-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $222.02 | 2022-2023 | Acuvue |
| Alcon Vision LLC | $208.50 | 2022-2025 | Tryptyr, Rocklatan |
| Horizon Therapeutics Plc | $124.74 | 2023 | Tepezza |
| Apellis Pharmaceuticals, INC. | $122.71 | 2024 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $62.05 | 2024 | Xdemvy |
| Visioneering Technologies, INC. | $53.39 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $19.51 | 2023 | |
| Sight Sciences, INC. | $18.06 | 2023 | Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Sol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.